100% correct. MMJ mentions this in their presentation that Phyto isn't included in the valuation. Phytotech with all the patents, research and intellectual property could be worth a lot in its own right given time. They could find a break-through that everyone will be scrambling for if it improves bio-availability of the MC drugs etc.
